AAVS1-Puro cTnT CCND2-T2A-ChloC-P2A-eGFP
(Plasmid
#179840)
-
Purposedonor plasmid for cardiac-specific CCND2-T2A-Chloc-P2A-eGFP expression in human cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 179840 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAddgene #136935
- Backbone size w/o insert (bp) 9222
- Total vector size (bp) 11939
-
Vector typeMammalian Expression, CRISPR, TALEN ; Donor plasmid
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCCND2
-
Alt nameKIAK0002
-
Alt nameMPPH3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)867
-
Entrez GeneCCND2 (a.k.a. KIAK0002, MPPH3)
- Promoter Troponin T promoter
-
Tags
/ Fusion Proteins
- chloride-conducting ChR (ChloC) (C terminal on insert)
- eGFP (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SalI (not destroyed)
- 3′ cloning site MluI (not destroyed)
- 5′ sequencing primer None
- 3′ sequencing primer None (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note: Plasmid contains E83Q and E101S mutations in CCND2. These mutations are not known to affect the plasmid's functions.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
AAVS1-Puro cTnT CCND2-T2A-ChloC-P2A-eGFP was a gift from Xiaoping Bao (Addgene plasmid # 179840 ; http://n2t.net/addgene:179840 ; RRID:Addgene_179840) -
For your References section:
Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study. Joshi J, Xu B, Rubart M, Chang Y, Bao X, Chaliki HP, Scott LR, Zhu W. Cells. 2022 Mar 10;11(6). pii: cells11060951. doi: 10.3390/cells11060951. 10.3390/cells11060951 PubMed 35326403